Metabolites 2012, 2(4), 913-939; doi:10.3390/metabo2040913
Review

Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches

Received: 31 October 2012; in revised form: 8 November 2012 / Accepted: 9 November 2012 / Published: 14 November 2012
(This article belongs to the Special Issue Glycomics and Glycoproteomics)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Glycans are important partners in many biological processes, including carcinogenesis. The rapidly developing field of functional glycomics becomes one of the frontiers of biology and biomedicine. Aberrant glycosylation of proteins and lipids occurs commonly during malignant transformation and leads to the expression of specific tumor-associated glycans. The appearance of aberrant glycans on carcinoma cells is typically associated with grade, invasion, metastasis and overall poor prognosis. Cancer-associated carbohydrates are mostly located on the surface of cancer cells and are therefore potential diagnostic biomarkers. Currently, there is increasing interest in cancer-associated aberrant glycosylation, with growing numbers of characteristic cancer targets being detected every day. Breast and ovarian cancer are the most common and lethal malignancies in women, respectively, and potential glycan biomarkers hold promise for early detection and targeted therapies. However, the acceleration of research and comprehensive multi-target investigation of cancer-specific glycans could only be successfully achieved with the help of a combination of novel high-throughput glycomic approaches.
Keywords: carbohydrate; malignancy; anti-glycan antibodies; tumor marker; microarray; glycomics; breast cancer; ovarian cancer
PDF Full-text Download PDF Full-Text [373 KB, uploaded 14 November 2012 10:00 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Pochechueva, T.; Jacob, F.; Fedier, A.; Heinzelmann-Schwarz, V. Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches. Metabolites 2012, 2, 913-939.

AMA Style

Pochechueva T, Jacob F, Fedier A, Heinzelmann-Schwarz V. Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches. Metabolites. 2012; 2(4):913-939.

Chicago/Turabian Style

Pochechueva, Tatiana; Jacob, Francis; Fedier, Andre; Heinzelmann-Schwarz, Viola. 2012. "Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches." Metabolites 2, no. 4: 913-939.

Metabolites EISSN 2218-1989 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert